Bone Marrow vs Liver as Site for Islet Transplantation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The goal of this study is to evaluate safety and efficacy of bone marrow (BM) as site for pancreatic islet transplantationin humans. Our hypothesis is that BM represents a better site than liver (currently the location of choice for this procedure) thanks to its potential capacity to favor islet engraftment. To address our hypothesis we propose herein a randomized phase II trial to compare BM and liver as sites for islet transplantation in T1D patients.
Epistemonikos ID: 015af7c5b8d82aad8322c36e271830370b094a6c
First added on: May 11, 2024